from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3462c/infA

LFCtreatmentdescriptionclass of inhibitor

0.714

Amikacinug/mL Amikacintranslation

0.652

Cap5-10ug/mL Capreomycintranslation

1.147

Rox10-50 ug/mL Roxithromycintranslation

0.533

SM2-5 ug/mL Streptomycintranslation

0.820

Tet5-10 ug/mL Tetracyclinetranslation

-1.872

Rif0.2-5ug/mL Rifampicintranscription

-2.197

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.405

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.278

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.202

CPZ10-50 ug/mL Chlorpromazinerespiration

0.215

Clofazimine10-13 ug/mL Clofaziminerespiration

0.344

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.261

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.800

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.114

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.068

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.039

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.072

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.749

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.379

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.775

KCN5-20 ug/mL Potassium cyaniderespiration

-0.412

NaN30.2-2 mM Sodium aziderespiration

-0.178

Nigericin50 uM Nigericinrespiration

-1.865

TRC10-150 ug/mL Triclosanrespiration

-1.064

TRZ10-25 ug/mL Thioridazinerespiration

1.872

Valinomycin0.5-10 uM Valinomycinrespiration

0.498

ZnSO42 mM ZnSO4respiration

0.544

menadione6-10 ug/mL Menadionerespiration

0.245

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.136

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.428

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.456

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.049

NRP_1Non-replicating persistence stage 1dosRassociated

0.771

Amp0.2mg/mL AmpicillincellWall

0.282

Cephalexin20-100 ug/mL CephalexincellWall

0.016

Cerulenin0.32-5 ug/mL CerulenincellWall

0.414

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.073

EMB10-20 ug/mL EthambutolcellWall

-0.209

Eta12-40 ug/mL EthionamidecellWall

-0.025

INH0.2-0.4 ug/mL IsoniazidcellWall

0.020

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.189

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.263

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.096

BZA0.12 mg/mL BenzamidearomaticAmides

0.553

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.549

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.145

H2O24 mM hydrogen peroxideDNAdamaging

0.607

Levo10 ug/mL LevofloxacinDNAdamaging

0.668

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.041

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.480

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.315

UVUV-irradiationDNAdamaging

0.891

ARP41-4 ug/mL Antitubercular compound ARP4?

0.174

Antimycin12.5-50 ug/mL Antimycin A?

0.084

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.253

PA_110-50 ug/mL Antitubercular compound PA-1?

0.407

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.486

PA8240.2-2 ug/mL PA-824?

-0.603

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.071

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.146

Verapamil50 uM Verapamil?

0.236

mercaptoethanol2 mM 2-Mercaptoethanol?

0.056

methoxatin10-20 ug/mL Methoxatin?